Dynex to Market Binding Site's Workstation

Under an expanded agreement, Dynex Technologies (Chelmsford, MA, USA) will market the DSX "walk-away” workstation of The Binding Site (Birmingham, UK).

The Binding Site will include in the workstation its full range of enzyme-linked immunosorbent assay (ELISA) kits and reagents, along with exclusive 24-hour service and support as part of a complete laboratory solution for the automation of autoimmune and infectious-disease assays.

Dynex Technologies is a leading manufacturer of microplate instrumentation incorporating advanced detection and automated sample handling, consumables, and accessories used in clinical diagnostics and biomedical research.

"We've very pleased to continue our long-term relationship with The Binding site as part of our strategy to partner with premier providers to expand the reach of our technologies and service clinical customers better,” stated Dr. Robert J. Rosenthal, CEO and president of Dynex. "We designed the DSX to be an open system so clinical laboratories can have the flexibility they need to run virtually any ELISA assay.”

The Binding Site specializes in the research, development, and production of immunodiagnostic kits and reagents for use in the investigation of diseases. The company has a global network of distributors.

"Now, through this expanded agreement we can better serve our customers with our entire range of autoimmune and infectious disease ELISA kits, and by providing the technical expertise to fully realize the potential of the DSX as an open-system platform,” commented Anne Grainger, vice president, sales and technical services.





Related Links:
Dynex
The Binding Site